Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AstraZeneca
Hoffmann-La Roche
Daiichi Sankyo
Bayer
Merck Sharp & Dohme LLC
Seagen Inc.